Citynet deploys ADVA ALM for comprehensive fiber monitoring
4.12.2019 11:00:00 EET | Business Wire | Press release
ADVA (FSE: ADV) today announced that Citynet (HALL AG Kommunal GmbH) has deployed the ADVA ALM fiber monitoring solution in its backbone network. The technology is now enhancing performance and reducing operating costs in the municipal utility and telecommunications provider’s infrastructure. With real-time insight into its fiber network, Citynet is able to rapidly locate and repair fiber breaks with minimal disruption, reducing truck rolls, lowering carbon footprint and improving sustainability. The solution ensures optimal service at carrier handover points and supports the delivery of high-value SLAs. Technical support and maintenance is provided by ADVA’s partner Componet.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191204005060/en/
ADVA's ALM technology is helping Citynet to reduce its carbon footprint (Photo: Business Wire)
“The ADVA ALM enables our repair teams to quickly detect and pinpoint any degradation in our fiber plant. It means no more wasted hours on futile site visits. With proactive maintenance we can also resolve many more issues before services are affected so that outages can be avoided altogether. In fact, the ADVA ALM is so effective that we expect the amortization within the coming months,” said Manuel Kofler, head of IT division, Citynet. “This simple device helps us deliver unbeatable performance and increase the value of our SLAs. Yet it’s the boost to sustainability that makes the ADVA ALM valuable both now and in the future. Reducing truck rolls is key to tackling our carbon footprint and protecting our environment in the long term.”
The ADVA ALM is now proactively assuring Citynet’s fiber infrastructure throughout western Austria. Built on the ADVA FSP 3000 platform and FSP 150 multi-layer edge technology, the regional backbone network is fully protected by round-the-clock service-agnostic monitoring and managed by ADVA’s powerful and easy-to-use Ensemble Controller. Now, Citynet can instantly and precisely locate breaks that could threaten mission-critical services. Maintenance teams can also quickly ascertain whether impairments are in Citynet’s own fiber plant or on a carrier’s side of the network. What’s more, ADVA’s passive sensors are deployed in sites with no available power for remote link monitoring of utility holes and ducts.
“Our unique monitoring technology has already had a significant impact on Citynet’s network and on the people who depend on it. With proactive, in-service monitoring of the integrity and performance of its fiber, Citynet is guaranteeing availability and safeguarding vital services,” commented Andreas Jelinek, senior director, sales, Eastern Europe, Russia and CIS, ADVA. “Working closely with its team, we’ve helped Citynet to transform its municipal fiber network into a truly sustainable infrastructure. With our ALM solution, it can concentrate on what it does best, producing sustainable energy and delivering high-quality services, safe in the knowledge that its network is continually monitored and running at maximum efficiency.”
About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we're building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com.
Published by:
ADVA Optical Networking SE, Munich, Germany
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191204005060/en/
Contact information
For press:
Gareth Spence
t +44 1904 699 358
public-relations@adva.com
For investors:
Stephan Rettenberger
t +49 89 890 665 854
investor-relations@adva.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
TIME Names Xenco Medical one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health1.5.2026 13:07:00 EEST | Press release
Time Magazine has named pioneering medical technology company Xenco Medical as one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health. Widely regarded as the most prestigious recognition in business and technology, being selected to the TIME100 List remains the most coveted accolade that a company can achieve globally. The TIME100 Impact Awards are given to only 5 recipients each year, making it the rarest of honors that a company can receive and a profound recognition of transformative, global impact. Xenco Medical was honored by Time as the sole recipient of the TIME100 Impact Award in Health in 2026, signifying its leading, global distinction in impact on healthcare. According to Time Magazine, the TIME100 Most Influential Companies list highlights “companies making an extraordinary impact around the world.” The honor bestowed by Time comes after Xenco Medical was named the 2025 Medical Device/ Diagnostics Company of the
Inspirit Capital Completes Acquisition of Kaplan Languages Group1.5.2026 02:17:00 EEST | Press release
Inspirit Capital, a specialist investor in corporate carve-outs, and Kaplan, the global education company, have announced the completion of Inspirit’s acquisition of Kaplan Languages Group (KLG) from Kaplan. Financial terms are not being disclosed. KLG, a leading global language education platform, comprises Kaplan International Languages, Alpadia Language Schools, Azurlingua, and ESL Education. Inspirit Capital will support KLG in delivering on its ambitious growth plans, whilst continuing its fundamental mission to transform lives through language education. The next phase of ownership will see the development and launch of a refreshed standalone brand identity for KLG, with further announcements to follow on this in due course. KLG will continue to use the Kaplan name under a transitional license from Kaplan, Inc. until a new brand is announced. About Kaplan Languages Group Since 2006, KLG has provided the highest quality language education and cultural immersion experiences. Kaplan
Grindr Nominates Three New Directors to Its Board of Directors1.5.2026 00:16:00 EEST | Press release
Grindr Inc. (NYSE: GRND), the Global Gayborhood in Your Pocket™, today announced the nomination of Rob Solomon, Lisa Gersh, and Fadi Hanna to stand for election to its Board of Directors at the Annual Meeting of Shareholders on June 2, 2026. Rob Solomon is a deeply seasoned technology CEO and operator in consumer internet and marketplaces. He has held CEO and COO roles at scaled platforms including GoFundMe, Groupon, and Kayak-predecessor SideStep, and is currently CEO of leading electric aviation company H55. Lisa Gersh is a CEO and long-tenured public company director with deep experience across consumer brands, media, and commerce. She has served on the Hasbro (NASDAQ: HAS) board since 2010 and has led businesses including Oxygen Media, GOOP, and Alexander Wang. Fadi Hanna is Chief Risk Officer at Bloomberg L.P., overseeing enterprise risk across the organization. He previously worked at J.P. Morgan and has served on the board of Immigration Equality. “Over the last few years, we bu
The Empire State Building Celebrates 95 Years as the ‘World’s Most Famous Building’30.4.2026 23:42:00 EEST | Press release
The Empire State Building (ESB), the “World’s Most Famous Building,” will celebrate its 95th anniversary on May 1, 2026, with new offers at the Empire State Building Observation Deck, a special birthday tower lighting display, and a slate of celebrations to honor its legacy and future. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430693323/en/ The Empire State Building Celebrates 95 Years as the ‘World’s Most Famous Building’ “The Empire State Building celebrates its 95th anniversary, still the ‘World’s Most Famous Building,’ a modernized, sustainability leader as technologically advanced today as the day she was completed, and the winner of #1 Top Attraction in the United States in Tripadvisor’s Travelers’ Choice Awards for 2026,” said Anthony E. Malkin, chairman and CEO of Empire State Realty Trust. Anniversary Offerings and Experiences To mark its 95th anniversary, the Empire State Building will debut new experiences
MRM Health’s Lead Candidate MH002 Granted Fast Track Designation by U.S. FDA for the Treatment of Mild-to-Moderate Ulcerative Colitis30.4.2026 23:17:00 EEST | Press release
MRM Health, a clinical-stage biopharmaceutical company developing therapeutics for immune-mediated diseases, which unlock the power of the microbiome to restore immune balance, today announced that MH002, the Company’s lead rationally designed Live Biotherapeutic Product (LBP) candidate, has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for the treatment of mild-to-moderate ulcerative colitis (UC). MH002 today is the most advanced LBP targeting inflammatory bowel disease (IBD)-specific mechanisms and is composed of a rationally designed microbial consortium of six well-characterized commensal strains. The FDA’s Fast Track is a process designed to facilitate the development and expedite the review of drugs to treat serious conditions and fill an unmet medical need. The purpose is to get important drugs to patients earlier. Fast Track designation enables frequent communication with the FDA to discuss the drug's development plan and ensure collection o
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
